BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 15488219)

  • 21. Histidines in potential substrate recognition sites affect thyroid hormone transport by monocarboxylate transporter 8 (MCT8).
    Braun D; Lelios I; Krause G; Schweizer U
    Endocrinology; 2013 Jul; 154(7):2553-61. PubMed ID: 23592749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations.
    Heuer H; Maier MK; Iden S; Mittag J; Friesema EC; Visser TJ; Bauer K
    Endocrinology; 2005 Apr; 146(4):1701-6. PubMed ID: 15661862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification, functional analysis, prevalence and treatment of monocarboxylate transporter 8 (MCT8) mutations in a cohort of adult patients with mental retardation.
    Visser WE; Vrijmoeth P; Visser FE; Arts WF; van Toor H; Visser TJ
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):310-5. PubMed ID: 22924588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics and phenomics of thyroid hormone transport by MCT8.
    Friesema EC; Visser WE; Visser TJ
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):107-13. PubMed ID: 20083155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient Activation of Pathogenic ΔPhe501 Mutation in Monocarboxylate Transporter 8 by Chemical and Pharmacological Chaperones.
    Braun D; Schweizer U
    Endocrinology; 2015 Dec; 156(12):4720-30. PubMed ID: 26368820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid hormone transporters in health and disease.
    Jansen J; Friesema EC; Milici C; Visser TJ
    Thyroid; 2005 Aug; 15(8):757-68. PubMed ID: 16131319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid hormone cell membrane transport defect.
    Ramos HE
    Endocr Dev; 2014; 26():108-17. PubMed ID: 25231447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy.
    Wirth EK; Sheu SY; Chiu-Ugalde J; Sapin R; Klein MO; Mossbrugger I; Quintanilla-Martinez L; de Angelis MH; Krude H; Riebel T; Rothe K; Köhrle J; Schmid KW; Schweizer U; Grüters A
    Eur J Endocrinol; 2011 Oct; 165(4):555-61. PubMed ID: 21813593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid hormone transporter defects.
    Grüters A
    Endocr Dev; 2007; 10():118-126. PubMed ID: 17684393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum triiodothyronine and intellectual and motor disability with paroxysmal dyskinesia caused by a monocarboxylate transporter 8 gene mutation.
    Fuchs O; Pfarr N; Pohlenz J; Schmidt H
    Dev Med Child Neurol; 2009 Mar; 51(3):240-4. PubMed ID: 19018842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype.
    Holden KR; Zuñiga OF; May MM; Su H; Molinero MR; Rogers RC; Schwartz CE
    J Child Neurol; 2005 Oct; 20(10):852-7. PubMed ID: 16417886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM; Kersseboom S; Yoon G; Visser TJ
    PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid hormone transporters and resistance.
    Visser TJ
    Endocr Dev; 2013; 24():1-10. PubMed ID: 23392090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8.
    Biebermann H; Ambrugger P; Tarnow P; von Moers A; Schweizer U; Grueters A
    Eur J Endocrinol; 2005 Sep; 153(3):359-66. PubMed ID: 16131597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid hormone transport in developing brain.
    Bernal J
    Curr Opin Endocrinol Diabetes Obes; 2011 Oct; 18(5):295-9. PubMed ID: 21825978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid hormone transport by monocarboxylate transporters.
    Visser WE; Friesema EC; Jansen J; Visser TJ
    Best Pract Res Clin Endocrinol Metab; 2007 Jun; 21(2):223-36. PubMed ID: 17574005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of monocarboxylate transporter 8 (mct8) disturbs brain development and locomotion in zebrafish.
    de Vrieze E; van de Wiel SM; Zethof J; Flik G; Klaren PH; Arjona FJ
    Endocrinology; 2014 Jun; 155(6):2320-30. PubMed ID: 24693966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of Reverse Triiodothyronine Level and the Triiodothyronine to Reverse Triiodothyronine Ratio in Dried Blood Spot Samples at Birth May Facilitate Early Detection of Monocarboxylate Transporter 8 Deficiency.
    Iwayama H; Kakita H; Iwasa M; Adachi S; Takano K; Kikuchi M; Fujisawa Y; Osaka H; Yamada Y; Okumura A; Hirani K; Weiss RE; Refetoff S
    Thyroid; 2021 Sep; 31(9):1316-1321. PubMed ID: 34049438
    [No Abstract]   [Full Text] [Related]  

  • 39. Surface translocation and tri-iodothyronine uptake of mutant MCT8 proteins are cell type-dependent.
    Kinne A; Roth S; Biebermann H; Köhrle J; Grüters A; Schweizer U
    J Mol Endocrinol; 2009 Dec; 43(6):263-71. PubMed ID: 19648159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations.
    Fischer J; Kleinau G; Müller A; Kühnen P; Zwanziger D; Kinne A; Rehders M; Moeller LC; Führer D; Grüters A; Krude H; Brix K; Biebermann H
    J Mol Endocrinol; 2015 Feb; 54(1):39-50. PubMed ID: 25527620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.